Advanced TP

Virtually All Studies Support IMRT  Dosimetric improvements influence:  Tumor control (coverage, dose escalation)  Normal tissue toxicity  The magnitude of these changes can be assessed in pre-clinical experiments or clinical trials – Requires equipoise, (difficult to achieve).

 Capital intensive, Learning curve.  Over time more flexible and efficient.